Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sansulin Log-G vs Lantus in Type 2 Diabetes
NCT04591457Phase 2Unknown
- Sponsor
- Universitas Indonesia
- Start
- Oct 2020
- Primary completion
- Aug 2021
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of Sansulin Log-G in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Universitas Indonesia. Primary endpoints: Glycated Hemoglobin at 24 weeks, Number of patients at 24 weeks and 1 more. Status: unknown.
02
Drugs
Sansulin Log-G
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT04591457.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04591457.